Real-time enrollment status for this renal cell carcinoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 3:23 PM UTC
| NCT Number | NCT06234605 |
| Recruiting Status | Recruiting |
| Condition | Renal Cell Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 80 participants |
| Active Locations | 21 sites in the US |
| Sponsor | HiberCell, Inc. |
| Last Updated on CT.gov | October 2, 2026 (1 week ago) |
As of October 12, 2026: Clinical trial NCT06234605 is currently recruiting participants. This phase1 study for renal cell carcinoma is actively seeking new participants at 21 locations across the United States. The study is sponsored by HiberCell, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06234605 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06234605 was last updated 1 week ago (October 2, 2026). HelloStudys verifies this status automatically.